Modal Labs, a startup specializing in AI inference infrastructure, is talking to VCs about a new round at a valuation of about $2.5 billion, according to four people with knowledge of the deal. Should ...
Scientists have found a key brain network that’s disrupted by Parkinson’s disease, according to a study published today in Nature. The results change doctors’ understanding of what causes Parkinson’s ...
Share on Facebook (opens in a new window) Share on X (opens in a new window) Share on Reddit (opens in a new window) Share on Hacker News (opens in a new window) Share on Flipboard (opens in a new ...
The network neuroscience theory General intelligence is not itself a skill or strategy, the researchers argued. It is a pattern—the tendency for diverse abilities to be positively correlated. The ...
Microsoft has come swinging in the battle of custom hyperscale silicon, debuting its “AI inference powerhouse” Maia 200 accelerator. Built on Taiwan Semiconductor Manufacturing Company's (TSMC) 3nm ...
The multibillion-dollar deal shows how the growing importance of inference is changing the way AI data centers are designed and operated. OpenAI has signed a multibillion-dollar agreement to buy ...
Google researchers have warned that large language model (LLM) inference is hitting a wall amid fundamental problems with memory and networking problems, not compute. In a paper authored by ...
The stock market saw a massive reversal on Thursday after an impressive morning rally sparked by NVIDIA’s big earnings beat. Stronger-than-expected September job numbers fueled worries that the ...
A new technical paper titled “MultiVic: A Time-Predictable RISC-V Multi-Core Processor Optimized for Neural Network Inference” was published by researchers at FZI Research Center for Information ...
Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...
Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin. Madison-based Exact Sciences, a maker and provider of cancer ...
Abbott announced Thursday morning that it is acquiring Exact Sciences for $21 billion. The deal values Exact Sciences at $105 per share, representing a 22% premium to the cancer screening company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results